Chun Kwong - Alibaba Health Financial Controller
| ALBHF Stock | USD 0.48 0.03 5.88% |
Insider
Chun Kwong is Financial Controller of Alibaba Health Information
| Phone | 852 2583 9333 |
| Web | https://www.alihealth.cn |
Alibaba Health Management Efficiency
The company has return on total asset (ROA) of (0.0168) % which means that it has lost $0.0168 on every $100 spent on assets. This is way below average. Alibaba Health's management efficiency ratios could be used to measure how well Alibaba Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jeff Oberlander | Leafly Holdings | N/A | |
| Aman Sood | High Tide | N/A | |
| Yang Chen | 111 Inc | 53 | |
| Anfeng Guo | 111 Inc | N/A | |
| Daniel Pingree | PetMed Express | N/A | |
| Monica Mu | 111 Inc | N/A | |
| Mark Moseley | PetMed Express | N/A | |
| Mia Scholz | Walgreens Boots Alliance | 58 | |
| Rosalind Brewer | Walgreens Boots Alliance | 62 | |
| Joy Avzar | High Tide | N/A | |
| Matthew Hulett | PetMed Express | 53 | |
| Neal Miller | SunLink Health Systems | N/A | |
| Pengcheng Zhu | 111 Inc | N/A | |
| Suresh Krishnaswamy | Leafly Holdings | 55 | |
| Harkirat Grover | High Tide | 42 | |
| Samuel Martin | Leafly Holdings | 40 | |
| Rebecca Warner | Leafly Holdings | N/A | |
| Aaron Radelet | Walgreens Boots Alliance | N/A | |
| Deidre Boulware | Leafly Holdings | N/A | |
| David Cotter | Leafly Holdings | 53 | |
| Carlos Pinto | Leafly Holdings | N/A | |
Management Performance
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 |
Alibaba Health Infor Leadership Team
Elected by the shareholders, the Alibaba Health's board of directors comprises two types of representatives: Alibaba Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alibaba. The board's role is to monitor Alibaba Health's management team and ensure that shareholders' interests are well served. Alibaba Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alibaba Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yanwu Tu, CFO Director | ||
| Ka Chun, Company Sec | ||
| Shunyan Zhu, Chairman CEO | ||
| Difan Shen, CEO, Executive Director | ||
| Chun Kwong, Financial Controller | ||
| Chun Yan, Company Sec |
Alibaba Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Alibaba Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 14.83 B | |||
| Shares Outstanding | 13.52 B | |||
| Shares Owned By Insiders | 64.61 % | |||
| Shares Owned By Institutions | 10.90 % | |||
| Price To Earning | 232.77 X | |||
| Price To Book | 7.69 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Alibaba Pink Sheet
Alibaba Health financial ratios help investors to determine whether Alibaba Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alibaba with respect to the benefits of owning Alibaba Health security.